FIELD: medicine.
SUBSTANCE: to determine the occurrence of recurrence with flow cytometry, the percentage of T-regs(CD3+CD4+CD25+CD127dim) of lymphocytes from CD3+CD4+cells in homogenates of tumor tissue samples and in the line of resection after surgical removal of the tumor is determined. If this value is higher than 11.1% in tumor tissue and 7.1% in the tissue of the resection line, the recurrence of the sarcoma is predicted.
EFFECT: use of this method allows predicting the occurrence of relapse in the treatment of soft tissue sarcomas by determining the percentage of lymphocyte subpopulation, since this population of cells influences the development of antitumor immune responses.
2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF ESOPHAGEAL CANCER PROGRESSION | 2016 |
|
RU2640954C1 |
METHOD FOR PREDICTING THE DURATION OF THE RELAPSE-FREE PERIOD OF SOFT TISSUE SARCOMAS OF THE EXTREMITIES IN MIDDLE-AGED AND ELDERLY WOMEN | 2022 |
|
RU2778616C1 |
METHOD FOR INDIVIDUAL PREDICTION OF PROGRESSION OF SQUAMOUS CELL ESOPHAGUS CANCER II-III STAGE AFTER SURGICAL TREATMENT | 2019 |
|
RU2712921C1 |
METHOD OF INTRAOPERATIVE PHOTODYNAMIC THERAPY IN COMBINED TREATMENT OF LOCALLY ADVANCED SOFT TISSUE SARCOMAS | 2020 |
|
RU2737704C2 |
METHOD OF TREATING RECURRENT SOFT TISSUE SARCOMAS USING LOCAL HYPERTHERMIA | 2015 |
|
RU2607961C2 |
METHOD FOR PREDICTION OF RECURRENT SOFT TISSUE SARCOMAS | 2013 |
|
RU2532332C1 |
METHOD OF CALCULATION OF FORECAST FOR EARLY DEVELOPMENT OF SKIN MELANOMA | 2017 |
|
RU2643761C1 |
METHOD FOR PREDICTION OF LIFE EXPECTANCY IN PATIENTS WITH METASTATIC TUMORS | 2023 |
|
RU2821659C1 |
MOUSE SPINDLE CELL SARCOMA CELL LINE 164 MSar FE | 2023 |
|
RU2796351C1 |
METHOD FOR PREDICTICTION OF EARLY RECURRENCE OF SUPERFICIAL BLADDER CANCER | 2016 |
|
RU2635534C1 |
Authors
Dates
2017-07-11—Published
2016-09-06—Filed